Hepatitis B Reactivation in Patients Treated with Direct-Acting Antivirals for Hepatitis C.
Digestive diseases (Basel, Switzerland)(2022)
摘要
Patients with HBV/HCV coinfection have a high risk of HBVr after DAA treatment and should receive antiviral prophylaxis. Patients with resolved infection have a low risk of HBVr and can be monitored by serial ALT measurements.
更多查看译文
关键词
Coinfection,DAA treatment,HBV reactivation,Hepatitis,Hepatitis B,Hepatitis C
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要